Amedisys (NASDAQ: AMED)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.120 | 1.230 | 0.1100 | ||||
REV | 558.840M | 545.257M | -13.583M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Amedisys (NASDAQ: AMED) through any online brokerage.
Other companies in Amedisys’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Signify Health (NYSE:SGFY), LHC Gr (NASDAQ:LHCG) and Agiliti (NYSE:AGTI).
The latest price target for Amedisys (NASDAQ: AMED) was reported by B of A Securities on Tuesday, June 21, 2022. The analyst firm set a price target for 102.00 expecting AMED to fall to within 12 months (a possible -11.78% downside). 32 analyst firms have reported ratings in the last year.
The stock price for Amedisys (NASDAQ: AMED) is $115.62 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Amedisys.
Amedisys’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Amedisys.
Amedisys is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.